Cargando…
Anti-Viral Therapy and Decreased Sexual Desire in Patients with Chronic Hepatitis C
PURPOSE: Peg-interferon (PegIFN)α2a or PegIFNα2b plus ribavirin (RBV) is the standard therapy for chronic hepatitis C virus (HCV) infection in Taiwan and Asia. It is commonly associated with adverse effects, but the issue of sexual and mental health is not well reported. This study aimed to evaluate...
Autores principales: | Hsiao, Po-Jen, Hsieh, Po-Fan, Chou, Eric Chieh-Lung, Lai, Hsueh–Chou, Peng, Cheng-Yuan, Su, Kuan-Pin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4978384/ https://www.ncbi.nlm.nih.gov/pubmed/27505293 http://dx.doi.org/10.1371/journal.pone.0160450 |
Ejemplares similares
-
Diagnostic Potential of Low Serum Platelet, Albumin and Prolong PT-INR for Overactive Bladder and Nocturia in Chronic Hepatitis-Related Liver Cirrhosis
por: Chuang, Po-Heng, et al.
Publicado: (2021) -
Bupropion for Interferon-Alpha-Induced Depression in Patients with Hepatitis C Viral Infection: An Open-Label Study
por: Chen, Wei-Chun, et al.
Publicado: (2015) -
A Comparative Observational Study to Evaluate the Efficacy of Mid-Urethral Sling with Botulinum Toxin A Injection in Urinary Incontinence Patients
por: Chang, Yi-Huei, et al.
Publicado: (2020) -
Botulinum toxin A for the Treatment of Overactive Bladder
por: Hsieh, Po-Fan, et al.
Publicado: (2016) -
New noninvasive index for predicting liver fibrosis in Asian patients with chronic viral hepatitis
por: Wang, Hung-Wei, et al.
Publicado: (2017)